Ocular coloboma is a common eye malformation resulting from incomplete fusion of the optic fissure during development. Coloboma is often associated with microphthalmia and/or contralateral anophthalmia. Coloboma shows extensive locus heterogeneity associated with causative mutations identified in genes encoding developmental transcription factors or components of signaling pathways. We report an ultra-rare, heterozygous frameshift mutation in FZD5 (p.Ala219Glufs*49) that was identified independently in two branches of a large family with autosomal dominant non-syndromic coloboma. FZD5 has a single coding exon and consequently a transcript with this frameshift variant is not a canonical substrate for nonsense-mediated decay. FZD5 encodes a transmembrane receptor with a conserved extracellular cysteine rich domain (CRD) for ligand binding. The frameshift mutation results in the production of a truncated protein, which retains the WNT-ligand binding domain but lacks the transmembrane domain. The truncated protein was secreted from cells, and behaved as a dominant-negative FZD5 receptor, antagonizing both canonical and noncanonical WNT signaling. Expression of the resultant mutant protein caused coloboma and microphthalmia in zebrafish, and disruption of the apical junction of the retinal neural epithelium in mouse, mimicking that of Fz5/Fz8 compound conditional knockout mutants. by guest on January 25, 2016 http://hmg.oxfordjournals.org/ Downloaded from 3 Our studies have revealed a conserved role of Wnt-Frizzled signaling in ocular development and directly implicate WNT-FZD signaling both in normal closure of the human optic fissure and pathogenesis of coloboma. by guest on January 25, 2016 http://hmg.oxfordjournals.org/ Downloaded from 32), zebrafish fzd5 morphants exhibited coloboma and microphthalmia phenotypes ( Fig. 2A-D ). In addition, over-expression of the FZD5-A219Xfs*49 mutant in zebrafish embryos also resulted in coloboma and microphthalmia ( Fig. 2E-J) . Surprisingly, these phenotypes were by guest on January 25, 2016 http://hmg.oxfordjournals.org/ Downloaded from Cytoskeleton Inc, cat. # Bk-124). Signal intensity was acquired by NIH ImageJ from three representative immunoblots. Light absorbance/optic density of HRP colorimetric reaction was measured (SpectraMax M), and the data was analyzed in Microsoft Excel.
INTRODUCTION
Ocular coloboma (OC) is a developmental structural defect caused by the abnormal persistence of the optic fissure in post-embryonic life. In combination with microphthalmia (small eyes) and anophthalmia (absent eyes), OC represents a spectrum of malformations that account for an estimated 10% to 15% of pediatric blindness (1) . Transcription factors and signaling pathways play crucial roles in optic cup morphogenesis and fissure closure (2, 3) . Accordingly, human genetic studies together with vertebrate models have implicated Bone Morphogenetic Protein (BMP) (4-7), Hedgehog (Hh) (8) , Retinoic Acid (RA) (9) (10) (11) and
Hippo (12) pathways in the pathogenesis of these ocular malformations (8, (13) (14) (15) . Defects in components of Wnt signaling have been attributed to syndromic and non-syndromic ocular diseases, including Norrie disease (16, 17) , osteoporosis-pseudoglioma syndrome (18) and familial exudative vitreoretinopathy (16, 17, (19) (20) (21) , but not with abnormalities associated with ocular morphogenesis.
A growing body of evidence from several vertebrate models indicates that Wnt signaling is indispensable in optic field development and ocular morphogenesis. In the Wnt pathway, non-canonical (β-catenin-independent) signaling interacts with canonical (βcatenin-dependent) signaling to control presumptive retinal versus forebrain fates (22) . Loss of non-canonical ligands, Wnt5 and Wnt11, causes failure of eye field segregation (22) , whereas inactivation of β-catenin prior to optic vesicle differentiation causes anophthalmia (23) . At later stages of development, the canonical pathway also contributes to optic cup morphogenesis, with overexpression of the Wnt inhibitor Dkk1 leading to abnormal lens formation and coloboma (24, 25) . Furthermore, loss of the Secreted Frizzled Related The Wnt receptor Frizzled-5 (Fzd5) mediates both canonical and non-canonical signaling (22, 27) . During eye field specification, Fzd5 is specifically expressed in evaginating eye precursors (28, 29) . In zebrafish, Wnt11-Fzd5 signaling promotes eye field specification using the non-canonical pathway (22) . In Xenopus, Fzd5 acting via the canonical pathway controls the neural potential of retinal progenitors through regulation of Sox2 (30). Mouse Fzd5 -/mutants display extreme optic cup invagination defects with failure to induce lens formation (31), whereas conditional Fzd5 mutants ( Supplementary Fig.1) exhibit both microphthalmia and coloboma with disrupted retinal epithelial apical junctions (27, 32) implicating Fzd5 in mammalian ocular morphogenesis and early neurogenesis.
Additionally, mouse knockout mutants of Lrp6, encoding Fzd co-receptor presumed to be in the canonical Wnt signaling pathway (33), demonstrate ocular phenotypes similar to those observed in the conditional Fzd5 mutants. We therefore hypothesized that mutations in FZD5 may be involved in the development of human congenital ocular malformations. In this study, we tested this hypothesis using two independent methods: an unbiased genetic screen, and a candidate gene approach. Both of these identified the same single novel frameshift mutation in FZD5 in a large, extended family in which non-syndromic OC segregated as an autosomal dominant disorder. Functional analysis of the mutant protein, using zebrafish and mouse retinal explants, strongly suggests a dominant negative effect on WNT signaling which is likely responsible for optic fissure closure defects. The present study therefore directly implicates WNT-FZD signaling in the pathogenesis of human coloboma.
RESULTS

A frameshift mutation in FZD5 causes automomal dominant coloboma
Whole exome sequencing (WES) was performed as part of the Rare Disease component of UK10K (www.uk10k.org) in five members of a large family with autosomal dominant OC (Family 3483; Fig. 1A -C). The affected individuals IV:6, V:1, VI:2 and VI:5 shared only one 5 ultra-rare variant (not present in ExAC, EVS, 1000G, UK10K internal databases); a frameshift mutation in FZD5 (c.656delCinsAG; p.Ala219Glufs*49, hereafter referred A219Xfs*49). This variant was then shown to co-segregate with the disease in all affected individuals available for testing with one exception, IV:7 (Fig. 1A) . IV:7 has bilateral coloboma but is "married-in" to the family being unrelated to the affected individuals VI:2, V:1, IV:1, IV:4 and IV:6 (his wife). He has no prior family history of eye malformations and no other plausible causative variants could be identified in his exome sequence data. Two unaffected individuals (III:2 & V:8) also carried the mutation and were considered as nonpenetrant. Targeted re-sequencing of FZD5 in an additional 380 unrelated coloboma patients from the MRC Human Genetics Unit Cohort as part of UK10K revealed no other potentially pathogenic variants.
Concurrently, FZD5 was screened as a candidate gene, based on mouse studies (27, 32), in 172 unrelated individuals with coloboma from cohorts at National Eye Institute (NEI), USA and University of Alberta (U of A), Canada. These studies revealed the identical A219Xfs*49 mutation in all four affected individuals from family 111, where each exhibited bilateral coloboma and related phenotypes [e.g., microphthalmia, and cataract] ( Fig. 1A, B ).
Haplotype analysis using five microsatellite markers flanking the FZD5 gene suggested a recent common ancestry between Family 3483 and Family 111 ( Supplementary   Fig. 2 ). Based on the information provided by family 3483 that individual II:4 had emigrated to North America, this female represented a plausible genetic link with Family 111. In addition, both families are of Mennonite ancestry and originated from the same region in Europe. For the purpose of calculating the two-point LOD score, we designated II:4 in Family 3483 as the maternal great-grandmother of individual I:2 in Family 111, which is the closest possible link based on information from Family 111. This was a conservative approach, as it would generate a minimum possible LOD score associated with co-segregation of the disease and the mutation in the combined family. The linkage analysis was performed using the R package paramlink. Co-segregation of the FZD5 mutation with coloboma in the extended pedigree gave a two-point LOD score =0) ranging from 3.9-4.2 using penetrance 6 values between 0.1-1. It was not possible to obtain an accurate estimate of the penetrance for this mutation as we were not able to examine or genotype all apparently unaffected individuals in both branches of the family. However, on the basis of the genotypes we can safely conclude a relatively high but incomplete penetrance of the disease mutation.
FZD5 has a single coding exon with a 5' non-coding exon. As such the A219Xfs*49 mutant transcript is not predicted to be a substrate for nonsense-mediated decay. The A219Xfs*49 mutation is thus likely to result in production of a truncated FZD5 protein with an intact highly conserved ligand-binding domain (extracellular cysteine rich domain, CRD) but lacking the seven transmembrane domains ( Fig. 1D ) ( Supplementary Fig. 3 ).
Within the NEI and U of A cohorts, one additional rare missense variant was identified (c. 290A>T; p.Asp97Val (D97V); Supplementary table 1, Supplementary Fig. 4A,   B ). This variant is of uncertain significance as this variant was not present in the unaffected mother or brother and the father was deceased ( Supplementary Fig. 4A ). This mutation did not significantly change FZD5 protein level or its membrane localization by in vitro transfection assay ( Supplementary Fig. 4C ). Atomic non-local environment assessment (ANOLEA) predicted that the D97V variant would perturb local interactions ( Supplementary   Fig. 4D ). Super Topflash (STF) reporter assays indicated a slight but consistent increase of Wnt9b-stimulated canonical Wnt activity by D97V mutation ( Supplementary Fig. 4E) suggesting a gain-of-function.
Altered expression of FZD5 A219Xfs*49 in zebrafish results in microphthalmia and coloboma
To elucidate the functional relevance of the human FZD5 A219Xfs*49 mutation, zebrafish were used as a model system. Concordant with observations in mouse Fzd5 mutants (27, 7 more prevalent when the wild type FZD5 protein was over-expressed ( Fig. 2K -L). We noted that the eye size was similar when either WT or FZD5-A219Xfs*49 mutant was overexpressed ( Supplementary Fig. 5 ). These observations suggest that precise FZD5 and/or Wnt signaling dosage is critical for ocular development. An engineered secreted FZD5-CRD protein (sCRD, fused with human Ig-Fc fragment) had an effect similar to the A219Xfs*49 FZD5 mutant ( Fig. 3C, D) , suggesting that the secretion of the latter is critical for its abnormal function. To examine whether A219Xfs*49 FZD5 binds to Wnt, co-IP experiments were conducted using cell extracts transfected with Wnt3a-myc, WNT7A-HA, FZD5 and FZD5 A219Xfs*49 constructs in different combinations (34, 35) . We detected binding of FZD5 A219Xfs*49 to WNT7A as well as FZD5 ( Supplementary Fig. 7 ), suggesting that a competition may exist between A219Xfs*49 FZD5 mutant and wild type for WNT utilization. 
DISCUSSION
In the present study, we have identified an ultra-rare frameshift mutation in FZD5 in a large domain. No phenotype information is available for the single individual carrying this mutation in a heterozygous state. Given that non-penetrance has been observed in at least two members of the family presented above, it is possible that this individual is non-penetrant or has microphthalmia, a disorder characterized by reduced ocular size that is closely associated with coloboma. An explanation for the rarity of such mutations may be related to the observation that Fzd5 null mouse embryos die before E11 due to placental angiogenesis defects (38) . The non-penetrance of such variants may reflect rescue via genetic background effects and/or compensation by paralogs. The latter effect is prominent in Supplementary Fig. 8 ), leading to microphthalmia and coloboma. The dominant-negative role of A219Xfs*49 mutant is also consistent with the absence of observable ocular defects in heterozygous Fzd5 null allelic mice.
To date, ocular disorders attributable to mutations in WNT signaling are Norrie disease (16, 17) , osteoporosis-pseudoglioma syndrome (18) and familial exudative vitreoretinopathy (16, 17, (19) (20) (21) . Our study directly implicates perturbed WNT signaling in coloboma and microphthalmia and is consistent with conclusions from mouse models (23, 27, 32, 33). FZD5 mediates both canonical and non-canonical Wnt signaling pathways in different organisms and tissues (22, 27, 30) . However, it is likely that FZD5-mediated non-canonical WNT signaling is the predominant pathway in the developing mammalian retina, as only minimal activity from the canonical pathway has been reported in these cells (39) . 
MATERIALS AND METHODS
Animal experiments
Animal Care and Use Committee of the National Eye Institute approved all procedures involving the use of mice. Fzd5 and Fzd8 compound mutants were created and maintained as described previously (32).
All zebrafish experiments were consistent with Canadian Council of Animal Care guidelines and approved by the University of Alberta's Animal Care and Use Committee (Protocol #427). Experiments utilized the wildtype AB zebrafish strain or Tg(TOP:dGFP)w25 transgenic strain (40) . All embryos were grown at 28.5°C and staged according to developmental hallmarks (41) .
Zebrafish morpholino and FZD5 mRNA injection experiments
Morpholino oligonucleotides (MO; GeneTools) were appropriately diluted in Danieau's solution, then heated to 65°C for 10 min and allowed to cool before injection into the 1-2 cell stage embryos. A previously described translation blocking MO targeting fzd5 (GATGCTCGTCTGCAGGTTTCCTCAT) was injected at a dose of 1.2 pmol (22) .
Morphological phenotypes were recapitulated by injecting a minimally overlapping MO (TGCAGGTTTCCTCA-TACTGGAAAGC) (data not shown). Human FZD5 WT and A219Xfs*49 cDNA was amplified using pRK5 constructs as template (see below) using the by guest on January 25, 2016 http://hmg.oxfordjournals.org/ Downloaded from following primer sequences: F -CACAGGATCCACCATGGCTCGGCCTG), R -CACAGAATTCCCTGAACCAAGTGGAA. PCR products were cloned into pCR4-TOPO (Invitrogen) for sequencing confirmation and sub-cloned into pCS2+ for mRNA synthesis.
Constructs were linearized with NsiI (New England Biolabs) and mRNA was generated using the SP6 mMessage mMachine kit (Ambion). mRNA was purified using YM-50 Microcon columns (Amicon, Millipore) and the concentration was determined through spectrophotometry. The mRNA was diluted with DEPC-treated water and injected at a dose of 200pg into 1-cell stage embryos.
Whole mount in situ hybridization, immunofluorescence and live imaging
Live zebrafish embryos were photographed using an Olympus stereoscope with a Qimaging micropublisher camera. Whole mount in situ hybridization was performed as previously described (42) . RT-PCR was used to generate 800-1200bp templates for probe synthesis or sub-cloned into pCR4-TOPO (Invitrogen). Immunofluorescence was performed as previously described (26) using rabbit polyclonal specific for Laminin (1/100) (Sigma L9393). After either in situ hybridization or immunofluorescence, eyes were dissected off and flat mounted for imaging on Zeiss AxioImager Z1 compound microscope with Axiocam HR digital camera. Sanger sequencing was used to test for the FZD5 mutation in all other available members of this branch of the family. Four affected individuals from family 111 (HREB) were Sanger sequenced for the FZD5 gene. Exome sequencing was performed as described (43) with BWA 0.5.9 used for alignment, Picard 1.43 for duplicate marking, GATK 1.0.5506 for realignment around indels and base quality scores recalibration, and GATK Unified Genotyper for variant calling. LOD score was calculated using paramlink package in R (44).
Patients and DNA sequencing
The oligonucleotides used to PCR amplify FZD5 are listed in supplementary table 2. Cell extracts were then prepared for Firefly luciferase and renilla luciferase assay using Dual-luciferase assay system (Promega, E1960). Luminicence was measured sequentially by Turner Biosystem Modulus microplate reader. Firefly luciferase activity was normalized against renilla luciferase, and p-value calculation was performed using Microsoft Excel software student t-test function.
Immunoblotting, immunofluorescence staining, and immunohistochemistry
Active RhoA assay for Wnt5 a stimulation
HEK293 cells were cultured to 80% confluence in DMEM:F12 in 6-well dishes, transfected with FZD5 WT, A219Xfs*49 and sCRD plasmids, cultured for 24 hrs, then serum starved for 24 hrs. Wnt5a recombinant protein conditioned medium (Wnt5a CM, Roche, Cat: 645-WN-010/CF) was applied for 30min at 250ng/ml. Cells were lysed and then subjected to active GTP-RhoA assays according to the manufacturer instructions (pulldown assay: Maximum LOD for combined family is 4.07 at θ = 0 penetrance = 0.8
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